Anne-Virginie Eggimann
Director/Board Member chez CODIAK BIOSCIENCES
Profil
Anne-Virginie Eggimann is currently an Independent Director at Codiak BioSciences, Inc. and the Chief Regulatory Officer at bluebird bio, Inc. He previously worked as an Executive Director at Voisin Consulting, Inc. Mr. Eggimann has a graduate degree from the University of California, Los Angeles and an undergraduate degree from the California Institute of Technology.
Postes actifs de Anne-Virginie Eggimann
Sociétés | Poste | Début |
---|---|---|
BLUEBIRD BIO, INC. | Corporate Officer/Principal | 01/09/2011 |
CODIAK BIOSCIENCES | Director/Board Member | 17/05/2021 |
Anciens postes connus de Anne-Virginie Eggimann
Sociétés | Poste | Fin |
---|---|---|
Voisin Consulting, Inc.
Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Voisin Consulting, Inc. provides product development consulting services. It guides biotechnology, pharmaceutical and medical technology manufacturers throughout product development and commercialization. The company was founded by Emanuelle M. Viosin in 1997 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Formation de Anne-Virginie Eggimann
University of California, Los Angeles | Graduate Degree |
California Institute of Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BLUEBIRD BIO, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Voisin Consulting, Inc.
Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Voisin Consulting, Inc. provides product development consulting services. It guides biotechnology, pharmaceutical and medical technology manufacturers throughout product development and commercialization. The company was founded by Emanuelle M. Viosin in 1997 and is headquartered in Cambridge, MA. | Commercial Services |
Codiak BioSciences, Inc.
Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. Codiak BioSciences was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA. | Health Technology |